Government of Zambia   Report issue

Government Phase 3 Phase 4
Founded: Lusaka Zambia (1991)

Organization Overview

First Clinical Trial
2011
NCT01241318
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Minister of Community Development, Mother and Child Health, Zambia | Ministry of Health, Zambia

Active Ingredients

Drugs in Phase 4 Trials (3)

dihydroartemisinin (2 trials)

ivermectin (stromectol) (1 trial)

piperaquine (2 trials)

Drugs in Phase 3 Trials (1)

chlorhexidine (hibitane) (1 trial)

Drugs in Other Trials (1)

praziquantel (biltricide) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5